Rubius Therapeutics Pink Sheet Forecast - Relative Strength Index
| RUBYDelisted Stock | USD 0.08 0.02 17.00% |
Rubius Pink Sheet Forecast is based on your current time horizon.
Rubius |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 35.98 | 35.98 |
| Check Rubius Therapeutics Volatility | Backtest Rubius Therapeutics | Trend Details |
Rubius Therapeutics Trading Date Momentum
| On March 06 2023 Rubius Therapeutics was traded for 0.08 at the closing time. The top price for the day was 0.10 and the lowest listed price was 0.08 . The trading volume for the day was 17.9 M. The trading history from March 6, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 36.15% . The trading delta at closing time against the current closing price is 23.08% . |
Rubius Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Rubius Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of Rubius Therapeutics could also be used in its relative valuation, which is a method of valuing Rubius Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Rubius Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Rubius Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Rubius Therapeutics shares will generate the highest return on investment. By undertsting and applying Rubius Therapeutics pink sheet market strength indicators, traders can identify Rubius Therapeutics entry and exit signals to maximize returns.
Rubius Therapeutics Risk Indicators
The analysis of Rubius Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Rubius Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting rubius pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 9.12 | |||
| Standard Deviation | 13.32 | |||
| Variance | 177.53 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Rubius Pink Sheet
If you are still planning to invest in Rubius Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rubius Therapeutics' history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |